NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/17/2025
Back to search
Official data from USPTO
DRUGWATCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
10/18/2025
Trademark type
Combined
Nice classes
44
Filing date
05/15/2015
Registration date
06/21/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2025
Last transaction
10/18/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
02/28/2012
First use in commerce
02/28/2012
Drawing code
3
Owner type
16
Owner location
Orlando, FL
Examiner
THOMAS, JANICE
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "drugwatch" and design of capsule inside two curves forming eye design in front of the word "drugwatch".
Holders and representatives
Holders
Drugwatch.com, LLC
Representatives
Hilary F. Steinberger STEINBERGER IP LAW
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing a website featuring information in the field of dangerous drugs and medical productslists of potentially dangerous drugs and medical productsfood and Drug Administration recalled drugs
Publications
History of USPTO decisions and trademark events.
28 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/17/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/17/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/17/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
06/25/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/21/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/18/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/18/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/18/2022
E815
TEAS SECTION 8 & 15 RECEIVED
06/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/21/2016
PUBO
PUBLISHED FOR OPPOSITION
04/05/2016
NPUB
NOTICE OF PUBLICATION
03/16/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/22/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/22/2016
CNFR
FINAL REFUSAL MAILED
02/03/2016
CNFR
FINAL REFUSAL WRITTEN
02/03/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2015
CNRT
NON-FINAL ACTION MAILED
09/02/2015
CNRT
NON-FINAL ACTION WRITTEN
09/01/2015
DOCK
ASSIGNED TO EXAMINER
08/27/2015
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
05/26/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/23/2015
NWAP
NEW APPLICATION ENTERED
05/19/2015
Continuous trademark protection
Get notified about every new filing that threatens DRUGWATCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.